These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20443975)
21. Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa. Jasinska-Myga B; Kachergus J; Vilariño-Güell C; Wider C; Soto-Ortolaza AI; Kefi M; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Yahmed SB; Sassi SB; Zouari M; El Euch G; Ross OA; Hentati F; Farrer MJ Mov Disord; 2010 Oct; 25(13):2052-8. PubMed ID: 20721913 [TBL] [Abstract][Full Text] [Related]
22. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor. Deng H; Le W; Davidson AL; Xie W; Jankovic J Neurosci Lett; 2006 Oct; 407(2):97-100. PubMed ID: 16939701 [TBL] [Abstract][Full Text] [Related]
23. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease. Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385 [TBL] [Abstract][Full Text] [Related]
24. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal. Ferreira JJ; Guedes LC; Rosa MM; Coelho M; van Doeselaar M; Schweiger D; Di Fonzo A; Oostra BA; Sampaio C; Bonifati V Mov Disord; 2007 Jun; 22(8):1194-201. PubMed ID: 17469194 [TBL] [Abstract][Full Text] [Related]
25. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease. Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113 [TBL] [Abstract][Full Text] [Related]
26. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation. Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782 [TBL] [Abstract][Full Text] [Related]
27. Common variants of LRRK2 are not associated with sporadic Parkinson's disease. Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973 [TBL] [Abstract][Full Text] [Related]
28. Absence of commonly reported leucine-rich repeat kinase 2 mutations in Eastern Indian Parkinson's disease patients. Sanyal J; Sarkar B; Ojha S; Banerjee TK; Ray BC; Rao VR Genet Test Mol Biomarkers; 2010 Oct; 14(5):691-4. PubMed ID: 20722494 [TBL] [Abstract][Full Text] [Related]
29. Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease. Funalot B; Nichols WC; Pérez-Tur J; Mercier G; Lucotte G Genet Test; 2006; 10(4):290-3. PubMed ID: 17253937 [TBL] [Abstract][Full Text] [Related]
30. Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis. Wu X; Tang KF; Li Y; Xiong YY; Shen L; Wei ZY; Zhou KJ; Niu JM; Han X; Yang L; Feng GY; He L; Qin SY Parkinsonism Relat Disord; 2012 Jul; 18(6):722-30. PubMed ID: 22575234 [TBL] [Abstract][Full Text] [Related]
31. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Lesage S; Ibanez P; Lohmann E; Pollak P; Tison F; Tazir M; Leutenegger AL; Guimaraes J; Bonnet AM; Agid Y; Dürr A; Brice A; Ann Neurol; 2005 Nov; 58(5):784-7. PubMed ID: 16240353 [TBL] [Abstract][Full Text] [Related]
32. The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: phenotype in monozygotic twins. Munhoz RP; Wakutani Y; Marras C; Teive HA; Raskin S; Werneck LC; Moreno D; Sato C; Lang AE; Rogaeva E Mov Disord; 2008 Jan; 23(2):290-4. PubMed ID: 17999435 [TBL] [Abstract][Full Text] [Related]